Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1421-1432
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1421
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1421
Table 4 Recommendations for therapy in patients with genotypes 4, 5 and 6
Patient characterization | Recommended | Duration (wk) | Scientific evidence |
Genotype 4 | SOF + PEG + RBV | 12 | Atomic neurino |
SOF + LDV | 12 | Synergy | |
SOF + RBV | 12 | Egyptian | |
24 | |||
(cirrhotics and nulls responders) | |||
OBV + PTV + RBV (noncirrhotics) | 12 | Pearl-1 | |
Genotype 5 | SOF + PEG + RBV | 12 | Neutrino |
Genotype 6 | SOF + PEG + RBV | 12 | Atomic |
SOF + LDV | 16 | Electron-2 |
- Citation: González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22(4): 1421-1432
- URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1421.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1421